Medications

Nearly 7 in 10 Americans are on prescription drugs, study finds

Nearly 70 percent of Americans are on at least one prescription drug, and more than half take two, Mayo Clinic researchers say. Antibiotics, antidepressants and painkilling opioids are most commonly prescribed, their study ...

Diseases, Conditions, Syndromes

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

Inflammatory disorders

Trial asthma drug targets lung inflammation

University of Adelaide researchers at the Royal Adelaide Hospital are involved in the world's biggest study of its kind investigating a possible new treatment for asthma.

Pediatrics

After age 18, asthma care deteriorates

It is widely accepted that medical insurance helps older adults with chronic health problems to receive better care. But what about young adults between the ages of 18 and 25, a demographic that also tends to have the lowest ...

Health

Spring forward with 10 sleep tips

Daylight savings time is March 10 – that's when clocks "spring forward" at 2 a.m. and you lose an hour of sleep. Most Americans are already sleep-deprived, which can impact your mood and performance in the workplace and ...

Diseases, Conditions, Syndromes

Cost of medication and stigma leading asthma sufferers to risk health

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ ...

Diseases, Conditions, Syndromes

Urban school-based asthma treatment cost-effective

(HealthDay)—A program to administer asthma medication each day to urban children with asthma reduces symptoms and is cost-effective, according to research published online Feb. 11 in Pediatrics.

Medications

1990s trial gave early danger signs for asthma drugs

The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.

page 7 from 13